ASH 2022 Conference Coverage


 

ASH 2022 Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial ADVANCE IV: Efficacy & Safety of IV Efgartigimod in Adults With Primary ITP

80 views
December 22, 2022
0 Comments
Login to view comments. Click here to Login
Benign Hematology